U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Bizarre Patents

Patent No. 5823386

Reward Candy Dispenser for Personal Computers

A personal computer peripheral, battery powered reward candy dispenser which immediately presents students with a single candy for each problem completed correctly.

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 560/168 - Amidine, azomethine, ketimine or oxime in acid moiety


Subclass of Class 560 - Organic compounds -- part of the class 532-570 series
Definition: Compounds in which the acid radical contains the group =N-C=N-
No. of patents: 122
Last issue date: 04/08/2008


1        
NumberTitleIssue Date
7354905Prodrugs of thrombin inhibitors
There is provided compounds of formula I, R1O(O)C—CH2—(R)Cgl-Aze-Pab-R2I wherein R1 and R2 have meanings given in the description, which are useful as prodrugs of inhibitors of trypsin-li...
04/08/2008
7223745Proteasome inhibitors and methods of using the same
The present invention provides boronic acid compounds, boronic esters, and compositions thereof that can modulate apoptosis such as by inhibition of proteasome activity. The compounds and compositions can be used in methods of inducing apoptosis and treating disease...
05/29/2007
7135587Urea and urethane derivatives as integrin inhibitors
Novel urea and urethane derivatives of general formula (I) in which R1, R2, R3, R5, R5′, X, Y, B, m, n and o are as defined in Patent Claim 1, and physiologically acceptable salts or solvates thereof are integrin inhibitors and can be employed for combating...
11/14/2006
7015348Method for producing an optically active β-amino acid
To provide a producing method of an optically active β-amino acid useful as intermediate for the production of medicines, agricultural chemicals and physiologically active substances, by means of a catalytic and asymmetric synthesis method of high performance and a...
03/21/2006
6962905Pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug
A kit of parts containing (a) a pharmaceutical formulation including a low molecular weight thrombin inhibitor, or a pharmaceutically acceptable derivative thereof, in admixture with a pharmaceutically acceptable adjuvant, diluent or carrier, and (b) a pharmaceutica...
11/08/2005
6960588Tryptase inhibitors
Compounds of formula (I) in which M, B1, B2, B3, B4, B5, B6, A1, A2, A3, A4, A5, A6, K1 and K2 have the meanings as indicated in the description, are novel effective tryptase inhibitors. ...
11/01/2005
6951946Large scale synthesis of 1,2,4- and 1,3,4-oxadiazole carboxylates
Disclosed are efficient and scalable processes for preparing 1,2,4- and 1,3,4-oxadiazole carboxylates from readily available starting materials. ...
10/04/2005
6946527Modified polymeric shaped body, method for producing the same and use thereof
AGE precursors can be removed from blood, plasma or PBS buffer using a modified polymeric shaped body that can be produced by reaction of diaminoguanidine and/or triaminoguannidine with a staring polymeric shaped body carrying R—X residues, where R is an alkylene ...
09/20/2005
6919449Process for the preparation of cephalosporin intermediate and its use for the manufacture of cephalosporin compounds
The present invention relates to a method for the preparation of cephalosporin antibiotic of the formula (II), which comprises hydrolyzing and halogenating the ester of formula (III) by photochemical irradiation in one...
07/19/2005
6888022Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis
Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or i...
05/03/2005
6784311Method of producing 3-aminoalkanoic acid esters
Process for the preparation of 3-aminoalkanoic acid esters of the general formula: in which R is C1-6-alkyl and R1 is hydrogen, C1-6-alkyl or phenyl, or their salts, by catalytic hydrogen...
08/31/2004
6660246Ligands and metal complexes thereof
Novel compounds of the formula ##STR1## and novel complexes of these compounds with metals are useful in diagnostic and therapeutic methods....
12/09/2003
6608196Process for solid supported synthesis of pyruvate-derived compounds
Provided are processes for synthesizing structurally diverse pyruvate-derived compounds using a parallel approach on a solid phase support. Examples of such a solid phase support include resins which have also been used in solid phase peptide synthesis....
08/19/2003
6605688Low Viscosity imine reactive diluents and coating compositions made therefrom
This invention concerns low viscosity aldimine and ketimine reactive diluents having multi-imine functionality, which are useful in automotive refinish coating compositions, including a process for making them and the coatings that contain them....
08/12/2003
6482974Process and intermediate compounds for the preparation of pyrrolidines
Processes for the preparation of pyrrolidones (7 and 8) and pyrrolidines (9 and 10) from tri-O-acetyl-D-erythro-4-pentulosonic acid esters are described. The compounds are aza sugar analogs of D-ribofuranoside and are intermediates to drugs which regulate...
11/19/2002
6482973Process and intermediate compounds for the preparation of pyrrolidines
Processes for the preparation of pyrrolidones (7 and 8) and pyrrolidines (9 and 10) from tri-O-acetyl-D-erythro-4-pentulosonic acid esters are described. The compounds are aza sugar analogs of D-ribofuranoside and are intermediates to drugs which regulate...
11/19/2002
6465686Halogenated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
The present invention discloses halogenated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors....
10/15/2002
6420592Amino acid-derived phosponamidic anhydrides and methods of preparing the same
Phosphonamide compounds and methods of forming those compounds are provided. The inventive methods comprise forming a template opened-ring phosphonamide compound and optionally subjecting the template to a ring-closing metathesis reaction in the presence ...
07/16/2002
6365673Low viscosity imine reactive diluents and coating compositions made therefrom
This invention concerns low viscosity aldimine and ketimine reactive diluents having multi-imine functionality, which are useful in automotive refinish coating compositions, including a process for making them and the coatings that contain them....
04/02/2002
6348617Method for purifying pyruvic acid compounds
The present invention is directed to a method for purifying pyruvic acid compounds, which method comprises reacting a pyruvic acid compound of general formula (I): ##STR1## wherein R1 is an optionally substituted lower alkyl group, a lower ...
02/19/2002
6187920Pyridazinone derivatives
This invention provides pyridazinone derivatives encompassed by the following the formula: ##STR1## wherein, R1, R2, R3, R4, R5 and R7 represent a hydrogen atom and the like, and R6
02/13/2001
6130246Pesticides
The compounds of formula I ##STR1## wherein: a) X is O, and Y is OC1 -C4 alkyl; or b) X is O or S, and Y is NHCH3 have fungicidal properties and can be used in plant protection for controlling and preventing disease infest...
10/10/2000
6090974Alkyl 3-oxoalkanoate and process for the preparation thereof
This invention includes an alkyl 3-oxoalkanoate, and processes for its preparation and use for the synthesis of fatty hydroxylated amino acids, fatty amino alcohols and ceramides....
07/18/2000
6034137Cationic lipids for gene therapy
This invention provides novel cationic lipids, particularly guanidino lipids, and methods for their preparation. Also provided are polyanionic-lipid complexes comprising the lipids of the invention, their preparation and use to deliver biologically active...
03/07/2000
5994577Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus
The present invention provides novel compounds of the formula I and II for the treatment of non-insulin dependent diabetes mellitius (NIDDM) and a new use of known compounds for this purpose....
11/30/1999
5981511Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors
The current invention discloses hydroxyamidino derivatives useful as nitric oxide synthase inhibitors....
11/09/1999
59770251,3-oxazin-4-one derivative, herbicide containing same, and intermediate for preparing same
This invention provides 1,3-oxazin-4-one derivatives represented by following general formula (I): ##STR1## in which R1 represents a phenyl group which may be substituted; R2 represents a hydrogen atom or a lower alkyl group; R
11/02/1999
5948931Preparation and use of ଱-(hydroxyimino) phosphonoacetic acids
଱-(hydroxyimino)phosphonoacetic acids (also referred to as "଱,଱-disubstituted trifunctional oximes" and "Troika Acids") and their derivatives, and methods to prepare them are disclosed. Also disclosed are the structures and fragmentation...
09/07/1999
5945408Hydroxyanidino derivatives useful as nitric oxide synthase inhibitors
The current invention discloses hydroxyamidino derivatives useful as nitric oxide synthase inhibitors....
08/31/1999
5939392Method of thrombin inhibition
The invention relates to new competitive tripeptide inhibitors of trypsin-like serine proteases, their synthesis, pharmaceutical compositions containing the compounds as active ingredients, and the use of the compounds as thrombin inhibitors, anticoagulan...
08/17/1999
5935988Tolerability of pharmaceutically active ଲ-amino acids
The present invention relates to mixtures of ଱-amino acids and/or derivatives thereof and cyclopentane-ଲ-amino acids and/or derivatives thereof, dipeptides of the abovementioned ଱-amino acids and cyclopentane-ଲ-amino acids and mixt...
08/10/1999
5914319Antithrombotic agents
This invention relates to thrombin inhibiting compounds having the Formula I X--Y--NH--(CH2)r --G I where X, Y, r and G have the values defined in the description, as well as pharmaceutical formulations contain...
06/22/1999
5863931Amidino derivatives and their use as nitric oxide synthase inhibitors
Amidino derivatives of formula (I) and salts, and pharmaceutically acceptable esters and amides thereof, in which: R1 is a C1-6 straight or branched chain alkyl group, a C2-6 alkenyl group, a C2-6 alkynyl group,...
01/26/1999
5861533Process for nitrosation of C-H-acidic compounds
A process for nitrosating C-H-acidic compounds. The process substantially avoids producing polluted wastewater....
01/19/1999
5847195Process for the production of compounds containing aspartate and aldimine groups
The present invention relates to a process for preparing compounds containing aspartate and aldimine groups corresponding to the formula ##STR1## by a) reacting 50 to 95 mole % of the primary amino groups present in a polyamine containing 2 to 6 prim...
12/08/1998
5726159Antithrombotic agents
This invention relates to thrombin inhibiting compounds having the Formula I X--Y--NH--(CH2)r --G I where X, Y, r and G have the values defined in the description, as well as pharmaceutical formulations containi...
03/10/1998
5710130Antithrombotic agents
This invention relates to thrombin inhibiting compounds having the Formula I X--Y--NH--(CH2)r --G I where X, Y, r and G have the values defined in the description, as well as pharmaceutical formulations containi...
01/20/1998
5710324Inhibitors of nitric oxide biosynthesis
The present invention is directed to a new class of compound which are useful as inhibitors of the biosynthesis of nitric oxide....
01/20/1998
5707967Pain relief compositions
Disclosed are compositions containing either aspartame or monosodium glutanate combined with an amino acid....
01/13/1998
5707966Antithrombotic agents
This invention relates to thrombin inhibiting compounds having the Formula I X--Y--NH--(CH2)r --G I where X, Y, r and G have the values defined in the description, as well as pharmaceutical formulations containi...
01/13/1998
1        
 
Sign InRegister
Username  
Password   
forgot password?